Carboxymethyl Beta-Cyclodextrin: Enhancing Drug Solubility and Release for Advanced Pharmaceutical Formulations

Discover the advanced applications of Carboxymethyl Beta-Cyclodextrin in pharmaceuticals. This key excipient offers superior solubility enhancement and controlled release capabilities, making it ideal for developing next-generation drug formulations.

Get a Quote & Sample

Key Product Advantages

Excellent Solubility Profile

CM-beta-CD exhibits excellent solubility in the human intestinal pH range of 6-7, making it an effective tool for enhancing the solubility of challenging drug molecules.

Reduced Hemolysis

Compared to other common derivatives like HP-β-CD, Carboxymethyl Beta-Cyclodextrin demonstrates a lower hemolysis rate, contributing to improved safety and tolerability in pharmaceutical applications.

Versatile for Extended Release

This derivative is well-suited for use in prolonged drug release formulations, offering pharmaceutical scientists greater control over drug delivery kinetics.

Key Applications

Drug Solubility Enhancement

Effectively tackles the challenge of low solubility for many active pharmaceutical ingredients, a critical factor in achieving therapeutic efficacy.

Prolonged Drug Release

Enables the development of sustained-release dosage forms, reducing dosing frequency and improving patient outcomes.

Pharmaceutical Formulations

Serves as a vital excipient in creating advanced pharmaceutical products, enhancing stability and bioavailability.

Biocompatible Excipient

Offers a favorable safety profile, including lower hemolysis, making it suitable for various parenteral and oral drug delivery systems.